DECEMBER ANNOUNCEMENTS
Despite the pandemic, 2021 has been a year of innovation and achievement at the Helen Diller Family Comprehensive Cancer Center. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, community groups, and government and industry partners to improve the quality of cancer prevention, treatment, and survivorship. As the year winds down, we take a moment to reflect on some highlights. [read more]
feature
In 2021, the Helen Diller Family Comprehensive Cancer Center funded pilot projects in computational cancer research, pancreatic cancer, immunotherapy, AI and imaging, and more.
feature
The UCSF cBioPortal is an open-source platform that allows for visualization, exploration, and analysis of cancer genomic datasets.
New Catchment Area Dashboard
icon
View a customized dashboard for querying and visualizing population-based cancer incidence and mortality data for the Cancer Center's catchment area.
Welcome New Members
Ryan Lokken, MD – Associate Member, Molecular Oncology

Aras Mattis, MD, PhD – Associate Member, Molecular Oncology

Tomasz Nowakowski, PhD - Associate Member, Pediatric Malignancies

Vijay Ramani, PhD – Associate Member, Molecular Oncology

Aaron Tward, MD, PhD – Associate Member, Molecular Oncology

Lei Wang, PhD – Member, Molecular Oncology

Liang You, MD, PhD – Associate Member, Molecular Oncology
Awards & Distinctions
Cammie Edwards, PhD has been appointed Director of Scientific Programs for the UCSF Living Therapeutics Initiative (LTI). Read more.

Kevin M. Shannon, MD and D. Wade Clapp, MD (Indiana University) are co-principal investigators of an $11.4 million SPORE focused on new treatments for tumors that develop in neurofibromatosis type 1 (NF1), the most common inherited syndrome causing a predisposition to cancer. Read more.

Bjoern Schwer, MD, PhD received a Carol and Gene Ludwig Award for Early Career Research from the Ludwig Family Foundation.

Valerie Weaver, PhD received the 2022 Shu Chien Achievement Award from the Biomedical Engineering Society (BMES). The award recognizes an individual who has made exceptional contributions to the field of cellular and molecular bioengineering.

Ivan de Kouchkovsky, MD received a 2021 PCF Young Investigator Award for a project, "Therapeutic Implications of Low PSMA PET Uptake in Castration-Resistant Prostate Cancer."

Julian Hong, MD received a 2021 ASTRO-PCF Early Career Development Award to End Prostate Cancer for a project, "Artificial Intelligence Approaches for the Diagnosis and Treatment of Oligometastatic Prostate Cancer."

Haolong Li, PhD received a 2021 PCF Young Investigator Award for a project, "Investigating PTGES3 as a Novel Therapeutic Target in Advanced Prostate Cancer."

Martin Sjöström, MD, PhD received a 2021 PCF Young Investigator Award for a project, "Using 5-Hydroxymethylcytosine (5hmC) Sequencing to Investigate Treatment Resistance and Develop Liquid Biomarkers for Advanced Prostate Cancer."


In the News
news
news
news
news
news
news
Recent Publications
Liu Q, Chen G, Moore J, Guix I, Placantonakis D, Barcellos-Hoff MH. Exploiting Canonical TGFβ Signaling in Cancer Treatment. Mol Cancer Ther. 2021 Oct 20.


Lyles CR, Wachter RM, Sarkar U. Focusing on Digital Health Equity. JAMA. 2021 Nov 9;326(18):1795-1796.

Lucas CG, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, Gener M, Ginn KF, Prall OWJ, Xu H, Kee D, Ko HS, Yaqoob N, Zia N, Florez A, Cha S, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA. EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. Acta Neuropathol. 2021 Nov 25.

Perera RM. Zooming in on the cell biology of disease. Mol Biol Cell. 2021 Dec 1;32(22):ae4.
Education & Training

This program will match HDFCCC staff applying for med school with current UCSF med students to receive mentoring on their application essays. Additionally, participants will be organized into small groups to receive feedback from each other. Open to all HDFCCC staff. Learn more and apply.
training
Opportunity to Present Your Work

The Parnassus Research In Progress Seminar (PRIPS) is looking for presenters. The seminar meets on Tuesdays at 4pm via zoom. Presenting at this seminar is a great opportunity to practice speaking in front of an audience of diverse scientific backgrounds. Open to grad students, SRAs, postdocs, and faculty. Email [email protected] if interested. 
Community Engagement
Jan 19, 2022 | 12:00 - 1:00 pm

Join the Office of Community Engagement for a quarterly lecture series highlighting important cancer related information impacting diverse communities. Learn more.
community
Featured Tweet
icon
twitter
Upcoming Events
Featuring guest speaker Kirsten Bryant, PhD, University of North Carolina.

Jennifer Rosenbluth, MD, PhD, will present, "Modeling breast cancer development and risk using patient-derived organoids."

Featuring guest speaker Dan Landau, MD, PhD, New York Genome Center.

Please join Dr. Hope Rugo and her colleagues as they share updates from the San Antonio Breast Cancer Symposium (SABCS).

This inaugural event will bring together those with interest in cognition and cancer from across the Cancer Center and UCSF to provide an opportunity to understand the current ongoing work and generate opportunities for collaboration and funding.